---
title: "AI powered structural heart planning software gains US FDA clearance"
date: "2024-09-19T08:41:21.000Z"
publishedDate: "19 septembre 2024"
summary: "Dasi Simulations has announced that its second product—Dasi Dimensions—has earned US Food and Drug Administration (FDA) clearance. “Our mission—to provide an artificial intelligence (AI)-powered structural heart platform that allows physicians to be more efficient and use their expertise more effectively—is moving forward with great momentum,” said Teri Sirset, founder and CEO, following the milestone."
importance: ""
sourceUrl: "https://cardiovascularnews.com/ai-powered-structural-heart-planning-software-gains-us-fda-clearance/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-09-19-ai-powered-structural-heart-planning-software-gains-us-fda-clearance"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/08/digital-code.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/ai-powered-structural-heart-planning-software-gains-us-fda-clearance/"
---

![AI powered structural heart planning software gains US FDA clearance](https://cardiovascularnews.com/wp-content/uploads/sites/14/2021/08/digital-code.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/ai-powered-structural-heart-planning-software-gains-us-fda-clearance/*

## L’essentiel

Dasi Simulations has announced that its second product—Dasi Dimensions—has earned US Food and Drug Administration (FDA) clearance. “Our mission—to provide an artificial intelligence (AI)-powered structural heart platform that allows physicians to be more efficient and use their expertise more effectively—is moving forward with great momentum,” said Teri Sirset, founder and CEO, following the milestone.

## Lien source

https://cardiovascularnews.com/ai-powered-structural-heart-planning-software-gains-us-fda-clearance/
